Actos Bladder Cancer Lawsuit
The U.S. Food and Drug Administration (FDA) has informed the public that use of the diabetes medication Actos (pioglitazone) for much more than 1 year may possibly be related with an elevated risk of bladder cancer. Details about this risk will be added to the Warnings and Precautions section of the label for pioglitazone-containing medicines, [...]